Goldman Sachs
ACLX

Goldman Sachs’s Arcellx ACLX Stock Holding History

Goldman Sachs’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$151M Buy
1,312,155
+643,675
+96% +$56.8M 0.02% 820
2025
Q4 		$43.6M Buy
668,480
+220,039
+49% +$17.6M 0.01% 1622
2025
Q3 		$36.8M Sell
448,441
-62,164
-12% -$4.48M ﹤0.01% 1680
2025
Q2 		$33.6M Buy
510,605
+335,817
+192% +$20.9M ﹤0.01% 1651
2025
Q1 		$11.5M Sell
174,788
-115,223
-40% -$7.81M ﹤0.01% 2561
2024
Q4 		$22.2M Sell
290,011
-9,248
-3% -$799K ﹤0.01% 2023
2024
Q3 		$25M Buy
299,259
+41,092
+16% +$2.74M ﹤0.01% 1853
2024
Q2 		$14.2M Sell
258,167
-14,626
-5% -$795K ﹤0.01% 2171
2024
Q1 		$19M Sell
272,793
-82,900
-23% -$5.26M ﹤0.01% 1884
2023
Q4 		$19.7M Sell
355,693
-519,165
-59% -$23.4M ﹤0.01% 1898
2023
Q3 		$31.4M Sell
874,858
-144,056
-14% -$4.97M 0.01% 1419
2023
Q2 		$32.2M Sell
1,018,914
-251,812
-20% -$9.63M 0.01% 1441
2023
Q1 		$39.2M Buy
1,270,726
+1,148,609
+941% +$34.8M 0.01% 1242
2022
Q4 		$3.78M Buy
122,117
+33,938
+38% +$778K ﹤0.01% 3422
2022
Q3 		$1.66M Buy
+88,179
New +$1.69M ﹤0.01% 4126
2022
Q2 		– Sell
-58,059
Closed -$814K – 6421
2022
Q1 		$814K Buy
+58,059
New +$971K ﹤0.01% 4990

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Goldman Sachs's ACLX Position: Q1 2026 in Review

Goldman Sachs increased its Arcellx (ACLX) stake by 96% in Q1 2026, buying an estimated $56.8M and bringing the position to 1,312,155 shares worth $151M. The position accounts for 0.02% of the portfolio, ranked #820.

Goldman Sachs first reported a position in ACLX in Q1 2022 and has held it in 16 quarters since. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Goldman Sachs held 1,312,155 shares of Arcellx worth $151M as of Q1 2026.
  • Goldman Sachs bought 643,675 Arcellx shares in Q1 2026, an estimated $56.8M.
  • Arcellx made up 0.02% of Goldman Sachs's portfolio in Q1 2026, its #820 holding.
  • Goldman Sachs first reported a position in Arcellx in Q1 2022 and has held it in 16 quarters since.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.